|
1 |
Amikacin Data Sheet. Auckland: Baxter Healthcare Ltd., 2000.
|
|
2 |
Amikin®
Data Sheet. Australia: Bristol-Myers Squibb,2001.
|
|
3 |
Stockley I. Drug Interactions 5th ed. London :The Pharmaceutical
Press; 2000.
|
|
4 |
Northern Neonatal Network. Neonatal Formulary 3. London: BMJ Books, 2000.
|
|
5 |
Sweetman S (ed.) Martindale: The Extra Pharmacopoeia. (33rd ed).
London : Royal Pharmaceutical Society; 2002.
|
|
6 |
Trissel LA. Handbook of Injectable Drugs (10th edition). American
Society of Hospital Pharmacists; 1998: Bethesda
|
|
7 |
Treluyer JM, Merle Y, Tonnelier S, Rey E, Pons G. Nonparametric population
pharmacokinetic analysis of amikacin in neonates, infants, and children.
Antimicrob Agents Chemother 2002; 46:1381-7.
|
|
8 |
Young
TE, Mangum B. Neofax. 15th edition. Acorn publishing (Raleigh) 2002. P4-5.
|
|
9 |
Kotze
A, Bartel PR, Sommers DK. Once versus twice daily amikacin in neonates:
prospective study on toxicity. J Paediatr Child Health 1999; 35:283-6.
|
|
10 |
Shore
K, Morris A. Amikacin as a replacement aminoglycoside for netilmicin
for coagulase-negative staphylococcal sepsis in neonates (letter).
NZMJ 2001; 115(1163):216
|
|
11 |
Prober
CsG, Yeager AS, Arvin AM. The effect of chronological age on the serum
concentrations of amikacin in sick and preterm infants. J Pediatr 1981;
98:636.
|
|
12 |
Myers
MG, Roberts RJ, Mirhij NH. Effects of gestational age, birthweight and
hypoxaemia of pharmacokinetics of amikacin in serum of infants. Antimicrob
Agents Chemother 1977; 11:1027.
|
|
13 |
Nursing 97 Drug Handbook 1997 Springhouse p67-8.
|